House Oversight and Government Reform Committee Hearing
My name is
It is critically important to me and to my wife that we do our part to ensure that discussions about this scourge are personalized. In prior committee hearings, you have heard the appalling statistics about the explosion of opioid prescriptions, addiction rates and overdose deaths. I am intimately familiar with them and will not repeat them here. But those discussions are often far too clinical. As you, federal officials, state officials and public health practitioners deliberate and consider solutions, it is far too easy to become detached. As you proceed, I implore you to recall the personal impacts - we are not just speaking about shocking, obtuse statistics - we are speaking about my son, your daughter and our neighbors. They are real people, with real lives, suffering from a disease and their losses are the face of the epidemic we must stop.
Allow me to briefly share my son's story. On
Kevin came to his addiction as a working adult while pursing his talent and passion working in the film industry in
Like so many, he underestimated them.
While working, he began self medicating issues with anxiety and depression with the widely available opioid prescription drug OxyContin - which is a common story as many struggling with mental health issues develop co-incident addiction problems. He quickly became dependent and then addicted. He returned home to
Like many struggling in search of treatment, he tried a variety of pathways including in-patient detoxification, intensive out-patient, medication assistance with buprenorphine, step program support and an outrageously expensive 28-day abstinence only residential program. Some of these were covered by insurance but others were covered out-of-pocket. But, like others in pursuit of recovery, he experienced the painful and common process of seeming progress followed by relapse. Days before he was to start a program of the medically-assisted treatment drug, naltrexone, he used again, and did not recover.
The short bio description I just gave you is an example of how the scourge of the opioid addiction epidemic before us today has no stereotypical victim. It is affecting people of all walks of life, all income levels and all backgrounds. This epidemic and my son's addiction do not respect income, social status or intelligence. That's what epidemics do. That point bears repeating in every hearing this committee conducts which touch upon this health crisis.
Since my son's loss, I have learned a great deal about the disease of addiction, this current epidemic, its underlying causes and painfully for me and my wife, some evidence-based treatment opportunities that offer hope, but now, only for others.
From the perspective of an impacted parent, as a citizen and as an advocate, I would like to add my voice to thousands traveling the same journey about some imperatives needed to stem the tide of the epidemic before us.
The first is the primary topic of this hearing. The need for a strong, well resourced and effective ONDCP has never been more important. A policy office directly tied to the Office of the President not only sends a message to the public about the importance of effective drug policy but it also ensures more effective development of integrated, cross-federal government programs and policies. ONDCP plays an essential role in being an integrator and coordinator for the widely disparate addiction fighting efforts of HHS's SAMHSA, NIDA,
The second imperative is reliable, continuous coverage of addiction treatment, especially medication-assisted therapy, as an essential benefit under any proposal to re-engineer our nation's health care system. Even with a good family insurance plan and the benefit of continued young-adult coverage provided by the Affordable Care Act, finding physicians with authorization to prescribe buprenorphine was difficult for my son. We must find ways to expand the number of physicians prescribing addiction fighting medications and also ensure insurance companies and providers do so at a reasonable cost.
Access to medication-assisted treatment already remains elusive for far too many patients - changes to the nation's health care system that remove mental health and substance use disorder coverage as an essential benefit will be a disaster for those, like my son, seeking such help.
Contemplated reductions in Medicaid coverage, which is now providing addiction treatment to vast numbers of people previously without any help, may become a death sentence for some. Finally, substitution of a possible opioid fund to offset Medicaid coverage, subject to annual appropriations decisions, is not an effective solution for a continuously expanding public health crisis.
Read this original document at: https://oversight.house.gov/wp-content/uploads/2017/07/Flattery-Statement-ONDCP-7-26.pdf
House Energy and Commerce Subcommittee on Health Hearing
Senate (Special Committee on) Aging Committee Hearing
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News